Mark W. Johnson, MD

Research Summary

Research interests include:  pathogenesis and treatment of epiretinal membrane, macular hole, vitreomacular traction syndrome, myopic traction maculopathy, and other vitreomacular conditions; intraocular pharmacotherapies for nonexudative and neovascular age-related macular degeneration; techniques and outcomes of macular and submacular surgery; evolution and complications of PVD; pathogenesis of macular and neuromacular disorders. 

Dr. Johnson serves as principal investigator at the Kellogg Eye Center for multicenter clinical trials examining the safety and efficacy of new drug treatments for nonexudative and neovascular age-related macular degeneration (AMD.  He serves on Data and Safety Monitoring Committees for numerous multicenter clinical trials investigating new treatments for macular and retinal vascular diseases and tumors. Other projects at the Kellogg Eye Center are studying the pathogenesis of uncommon macular disorders, optimal surgical strategies for repair of rhegmatogenous retinal detachment, best approaches to the treatment of proliferative diabetic retinopathy, and surgical management of vitreomacular and neuromacular disorders.